TipRanks
Go Ultimate55% OFF

Natural Health Trends (NAH) AI Stock Analysis

CH:NAH

Natural Health Trends

(BX Swiss:NAH)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong gross marginA gross margin above 75% provides meaningful economic room to fund distributor commissions, operating costs, and product development. The improvement tied to manufacturing closer to key markets may support margin durability if the company maintains product pricing and execution.
Negative Factors
Revenue contraction and China disruptionA sharp sales decline directly pressures the distributor network, product volumes, and the company’s ability to absorb fixed operating costs. China-related regulatory uncertainty and paused member activity could remain a durable headwind because Asia has historically been central to operations.

Natural Health Trends Business Overview & Revenue Model

Company Description

Natural Health Trends Corp. (NHTC) operates as an international enterprise specializing in direct sales and e-commerce. It distributes a diverse portfolio of personal care, wellness, and lifestyle products, all marketed under its NHT Global brand. Th...

Natural Health Trends Earnings Call Summary

Earnings Call Date:Jul 28, 2026(Q2-2026)|Next Earnings Date:Feb 09, 2027
Earnings Call SentimentNegative

The call presented a mix of operational improvements and new product momentum (margin expansion, restructuring savings, improved operating cash flow, product launch, and share repurchase authorization), but these positives were overshadowed by a pronounced revenue decline (-23% year-over-year), a swing to net loss, increased operating loss, significant cash reduction since year-end, and ongoing China-related headwinds and member misconduct that disrupted business. While management is taking disciplined steps to improve efficiency and engagement, near-term financial performance and market challenges weigh heavily on the outlook.

Positive Updates

Gross Margin Improvement
Gross profit margin increased to 75.2% from 73.9% year-over-year (up 1.3 percentage points), driven by transitioning much of product manufacturing from the U.S. to East Asia closer to main markets.

Negative Updates

Significant Revenue Decline
Second quarter net sales were $7.6 million, a 23% decrease from $9.8 million in Q2 2025, primarily due to cautious consumer spending and regulatory uncertainty in China that caused member activity pauses.

Company Guidance

The guidance emphasized financial discipline and execution to drive savings and position the business for recovery: Q2 net sales were $7.6M (down 23% YoY) while gross margin improved to 75.2% from 73.9% and commissions remained 40.9% of revenue; restructuring delivered roughly $300K of savings in the quarter and more than $600K year-to-date with additional savings expected in the second half, SG&A was $3.3M (down $323K YoY), operating loss was $643K (net loss $451K, or $0.05 per diluted share, versus net income $15K prior-year), and the company reported $18.6M of cash and marketable securities at June 30 (down from $28.9M at Dec. 31, 2025) after repurchases and dividends, used $2.2M of operating cash in the first six months (vs $5.2M a year earlier), resumed share repurchases with $15.9M available, and plans customer- and field-focused initiatives (including a 25th‑anniversary event expected to draw more than 1,000 attendees) to support long-term growth.

Natural Health Trends Risk Analysis

Natural Health Trends disclosed 40 risk factors in its most recent earnings report. Natural Health Trends reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

1 New Risk
1.Our business in China is subject to compliance with a myriad of applicable laws and regulations, and any actual or alleged violations of those laws or government actions otherwise directed at us could have a material adverse impact on our business and the value of our company.Q2, 2026

Natural Health Trends Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

CH:NAH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
OCGOCG52Neutral$3.10M0.00-6.73%―203.34%37.54%
MOGUMOGU49Neutral$15.45M49.560.35%―-9.81%―

* Consumer Cyclical Sector Average

Performance Comparison

-100%0%100%200%MOGUMIOCGJBDIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:NAH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MOGUMogu Inc1.97-0.71-26.49%
MINft Limited Class A0.38-321.22-99.88%
OCGOriental Culture Holding Ltd1.62-1823.15-99.91%
JBDIJBDI Holdings Limited2.470.2310.27%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.